0 points

Emily Fewster

Passionate about studying the psychedelic/mystical experience from a neuropsychological lens, Emily is a member of MAPS Canada Research Committee and graduated with an Honours BSc in Cognitive Neuropsychology from York University.  She currently leads a team of RAS with a randomized, double-blind, placebo-controlled clinical trial investigating microdosing psilocybin for persistent depressive disorder.
Gerard Artesona Psychedelic Therapist Oakland California
Patient Help

Meet Gerard Artesona: Psychedelic Integration Therapist and Spiritual Guide

Gerard Artesona is a psychedelic integration therapist from Oakland,California with a therapeutic aim to bridge Western psychology and psychedelic therapy, specifically entheogenic rituals to helps those managing psychological distress. Aside from his private practice, he works with Mindleap, a digital mental wellness platform that connects you with psychedelic integration specialists. Gerard also co-facilitates retreats at […]

By Emily
No Comments Read More
Brian Murphy Psychedelic Therapist New York City New York
Patient Help

Introducing Brian Murphy: Psychedelic and Psychospiritual Integration Therapist

Frshminds had the opportunity to learn about the work of Brian Murphy, a New York City psychedelic integration therapist, and how quickly integration is becoming recognized as an effective and powerful healing modality to treat a variety of mental health conditions such as depression, anxiety, trauma, and more.  Brian provides healing and psychedelic integration therapy […]

By Emily
No Comments Read More
Ketamine as a Rapid Onset Antidepressant
Research

Ketamine as a Rapid Onset Antidepressant

The discovery of ketamine as a rapid-onset antidepressant and further exploration into the processes involved could significantly impact treatment for patients as well as public health worldwide. Major Depressive Disorder: A Global Concern Major Depressive Disorder (MDD) impacts over 264 million people. This makes it the leading cause of disability globally. But, issues have been […]

By Emily
No Comments Read More
Psilocybin and Smoking Cessation
Research

Psilocybin and Smoking Cessation

Most smokers can attest to always looking to kick the habit, and now research is exploring the linkage between psilocybin and smoking cessation. Johns Hopkins researchers recently completed a study of 15 people taking psilocybin, the active hallucinogenic agent in “magic mushrooms.” In the study, smokers were dosed with psilocybin, and 80% of the participants […]

By Emily
No Comments Read More
Ketamine for Unipolar and Bipolar Depression
Research

Ketamine for Unipolar and Bipolar Depression

Early clinical trials demonstrate that using intravenous and intranasal ketamine for unipolar and bipolar depression offers the possibility for safe and rapid relief of symptoms with high response rates (up to 88%) and pronounced antisuicidal effects. Administration of Ketamine for Unipolar and Bipolar Depression The article below is part of Frshmind’s “Psychedelic Science Snapshot Series” […]

By Emily
No Comments Read More
Benefits of Microdosing Psychedelics
Microdosing

The Benefits of Microdosing Psychedelics

The benefits of microdosing psychedelics, which involves consuming sub-threshold doses of psychedelics such as LSD and psilocybin mushrooms, has recently been gaining more public attention. For example, the subreddit r/microdosing has seen a significant increase in its subscriber count within the past 2 years, growing from around 40,000 in November 2018 to almost 140,000 as […]

By Emily
No Comments Read More
MDMA Assisted Psychotherapy for PTSD
Research

MDMA Assisted Psychotherapy for PTSD

MDMA Assisted Psychotherapy for PTSD is a relatively recent area of study. While reports in the 1970’s described the potential for MDMA to facilitate communication and connection between therapists and patients, the 80’s saw the recreational use of MDMA became popular, leading to its classification as a Schedule 1 controlled substance in 1985, and thus […]

By Emily
No Comments Read More
Drug and Harm in the United Kingdom
Research

Drugs and Harm in the UK: Researching the Association

Introduction Drugs and harm in the UK has become a central political issue. Drugs such as alcohol and tobacco products are a major cause of harm to individuals and society. They are regulated by taxation, sales, and restrictions on the age of purchase. Concern about drugs and the harm they cause in the UK has […]

By Emily
No Comments Read More
Ketamine Assisted Psychotherapy
Research

Ketamine Assisted Psychotherapy (KAP): Demographics, Data and Outcomes

By now you’ve probably heard a bit about the potential benefits of ketamine assisted psychotherapy. Read on as Frshminds’ Emily Frewster takes you behind the curtain to explore a bit of the research into ketamine assisted psychotherapy. Ketamine Assisted Psychotherapy (KAP): Patient Demographics, Clinical Data and Outcomes in Three Large Practices Administering Ketamine with Psychotherapy […]

By Emily
No Comments Read More

Sign In

Don't have an account yet? Register

Forgot password?

Register

Reset Password

Please enter your username or email address, you will receive a link to create a new password via email.